{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:01:36Z","timestamp":1793152896038,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Region Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.euf.2025.09.003","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T20:27:18Z","timestamp":1766780838000},"page":"192-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Socioeconomic Status and Prostate-specific Antigen Testing: A Population-based Cohort Study Comparing Organised and Opportunistic Prostate Cancer Testing"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6216-0160","authenticated-orcid":false,"given":"Markus","family":"Arvendell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Abbadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lottie","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Nordstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2025.09.003_b0005","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.healthpol.2012.08.014","article-title":"An examination of variations in the uptake of prostate cancer screening within and between the countries of the EU-27","volume":"108","author":"Burns","year":"2012","journal-title":"Health Policy"},{"key":"10.1016\/j.euf.2025.09.003_b0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ypmed.2015.11.009","article-title":"Prostate cancer screening in Switzerland: 20-year trends and socioeconomic disparities","volume":"82","author":"Guessous","year":"2016","journal-title":"Prev Med"},{"key":"10.1016\/j.euf.2025.09.003_b0015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s40615-014-0061-z","article-title":"The relationship between education and prostate-specific antigen testing among urban African American Medicare beneficiaries","volume":"2","author":"Hararah","year":"2015","journal-title":"J Racial Ethn Health Disparities"},{"key":"10.1016\/j.euf.2025.09.003_b0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/21681805.2019.1681503","article-title":"Educational level and first-time PSA testing in general practice","volume":"53","author":"Lerhmann-Lerche","year":"2019","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euf.2025.09.003_b0025","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.juro.2013.04.044","article-title":"Socioeconomic variation and prostate specific antigen testing in the community: a United Kingdom based population study","volume":"190","author":"Morgan","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.09.003_b0030","doi-asserted-by":"crossref","first-page":"529.e9","DOI":"10.1016\/j.urolonc.2016.06.016","article-title":"Predictors of prostate cancer screening using Andersen's behavioral model of health services use","volume":"34","author":"Ogunsanya","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euf.2025.09.003_b0035","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jnci\/djt038","article-title":"Prostate cancer mortality in the Finnish randomized screening trial","volume":"105","author":"Kilpel\u00e4inen","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euf.2025.09.003_b0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.socscimed.2015.07.006","article-title":"Socioeconomic inequalities in prostate cancer survival: a review of the evidence and explanatory factors","volume":"142","author":"Klein","year":"2015","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.euf.2025.09.003_b0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejca.2011.07.009","article-title":"Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer","volume":"48","author":"Berglund","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.euf.2025.09.003_b0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/21681805.2017.1411392","article-title":"Eighteen-year follow-up of the G\u00f6teborg randomized population-based prostate cancer screening trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality","volume":"52","author":"Hugosson","year":"2018","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euf.2025.09.003_b0055","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/JU.0000000000002696","article-title":"Results from 22 years of followup in the G\u00f6teborg randomized population-based prostate cancer screening trial","volume":"208","author":"Fr\u00e5nlund","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2025.09.003_b0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.eururo.2019.02.009","article-title":"A 16-yr follow-up of the European randomized study of screening for prostate cancer","volume":"76","author":"Hugosson","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.09.003_b0065","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.2024.4011","article-title":"Prostate-specific antigen screening and 15-year prostate cancer mortality: a secondary analysis of the CAP randomized clinical trial","volume":"331","author":"Martin","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.euf.2025.09.003_b0070","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.eururo.2012.05.068","article-title":"Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)","volume":"62","author":"Schr\u00f6der","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.09.003_b0075","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","article-title":"Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up","volume":"384","author":"Schr\u00f6der","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.euf.2025.09.003_b0080","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2025.09.003_b0085","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1200\/JCO.2009.26.0133","article-title":"Time trends and local variation in primary treatment of localized prostate cancer","volume":"28","author":"Cooperberg","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2025.09.003_b0090","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa1201637","article-title":"Quality-of-life effects of prostate-specific antigen screening","volume":"367","author":"Heijnsdijk","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1016\/j.euf.2025.09.003_b0095","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.eururo.2014.12.006","article-title":"Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the G\u00f6teborg randomized population-based prostate cancer screening trial","volume":"68","author":"Arnsrud Godtman","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.09.003_b0100","article-title":"Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer","volume":"4","author":"Drost","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.euf.2025.09.003_b0105","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa2100852","article-title":"MRI-targeted or standard biopsy in prostate cancer screening","volume":"385","author":"Eklund","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2025.09.003_b0110","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa2406050","article-title":"Results after four years of screening for prostate cancer with PSA and MRI","volume":"391","author":"Hugosson","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2025.09.003_b0115","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMoa2209454","article-title":"Prostate cancer screening with PSA and MRI followed by targeted biopsy only","volume":"387","author":"Hugosson","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2025.09.003_b0120","unstructured":"Swedish National Board of Health and Welfare. Screening f\u00f6r prostatacancer \u2013 Rekommendation och bed\u00f6mningsunderlag. 2018. www.socialstyrelsen.se."},{"key":"10.1016\/j.euf.2025.09.003_b0125","unstructured":"Regional Cancer Centres in Sweden. Organised prostate cancer testing (OPT): description and recommendations. 2025. www.cancercentrum.se."},{"key":"10.1016\/j.euf.2025.09.003_b0130","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyaf062","article-title":"Data resource profile: STHLM0, the Stockholm Prostate Cancer Diagnostics Register","volume":"54","author":"Abbadi","year":"2025","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.euf.2025.09.003_b0135","unstructured":"Regional Cancer Centres in Sweden. Nationellt kvalitetsregister f\u00f6r SWEOPT. 2025. www.cancercentrum.se."},{"key":"10.1016\/j.euf.2025.09.003_b0140","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.euf.2022.06.008","article-title":"Designing and implementing a population-based organised prostate cancer testing programme","volume":"8","author":"Alterbeck","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2025.09.003_b0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2340\/sju.v60.43809","article-title":"Swedish regional population-based organised prostate cancer testing: why, what and how?","volume":"60","author":"Bratt","year":"2025","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euf.2025.09.003_b0150","article-title":"Associations between socioeconomic factors and PSA testing in a population-based organised testing programme and routine healthcare: a register-based study of 50-year-old men","volume":"3","author":"J\u00e4rbur","year":"2024","journal-title":"BMJ Oncol"},{"key":"10.1016\/j.euf.2025.09.003_b0155","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.breast.2021.05.011","article-title":"Population-based mammography screening attendance in Sweden 2017\u20132018: a cross-sectional register study to assess the impact of sociodemographic factors","volume":"59","author":"Lagerlund","year":"2021","journal-title":"Breast"},{"key":"10.1016\/j.euf.2025.09.003_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190171","article-title":"Socio-economic and demographic determinants affecting participation in the Swedish cervical screening program: a population-based case-control study","volume":"13","author":"Broberg","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.euf.2025.09.003_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101398","article-title":"Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: an analysis of health equity based on a randomised trial","volume":"47","author":"Str\u00f6mberg","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.euf.2025.09.003_b0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.prnil.2019.08.001","article-title":"A review of social determinants of prostate cancer risk, stage, and survival","volume":"8","author":"Coughlin","year":"2020","journal-title":"Prostate Int"},{"key":"10.1016\/j.euf.2025.09.003_b0175","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ijc.34932","article-title":"Socioeconomic inequality in prostate cancer diagnostics, primary treatment, rehabilitation, and mortality in Sweden","volume":"155","author":"Str\u00f6mberg","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.euf.2025.09.003_b0180","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/ijc.31272","article-title":"Socioeconomic status and diagnosis, treatment, and mortality in men with prostate cancer. Nationwide population-based study","volume":"142","author":"Tomic","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.euf.2025.09.003_b0185","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3109\/21681805.2015.1113200","article-title":"A population-based study on the association between educational length, prostate-specific antigen testing and use of prostate biopsies","volume":"50","author":"Nordstr\u00f6m","year":"2016","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euf.2025.09.003_b0190","doi-asserted-by":"crossref","first-page":"e1054","DOI":"10.1016\/j.clgc.2019.06.006","article-title":"Association of low socioeconomic status with adverse prostate cancer pathology among African American men who underwent radical prostatectomy","volume":"17","author":"Weprin","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euf.2025.09.003_b0195","doi-asserted-by":"crossref","unstructured":"Bertini A, Cirulli GO, Stephens A, et al. Socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivation Index on PSA screening frequency. BJU Int. In press. https:\/\/doi.org\/10.1111\/bju.16875.","DOI":"10.1111\/bju.16875"},{"key":"10.1016\/j.euf.2025.09.003_b0200","article-title":"Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population-based evaluation","volume":"4","author":"Dodkins","year":"2025","journal-title":"BMJ Oncol"},{"key":"10.1016\/j.euf.2025.09.003_b0205","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/jnci\/djt039","article-title":"Prostate-specific antigen testing in men aged 40-64 years: impact of publication of clinical trials","volume":"105","author":"Goodwin","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euf.2025.09.003_b0210","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eururo.2012.10.001","article-title":"Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, despite no recommendations for PSA screening: results from a population-based study, 2003\u20132011","volume":"63","author":"Nordstr\u00f6m","year":"2013","journal-title":"Eur Urol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456925002639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456925002639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:15:26Z","timestamp":1773947726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456925002639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2405456925002639"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2025.09.003","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Socioeconomic Status and Prostate-specific Antigen Testing: A Population-based Cohort Study Comparing Organised and Opportunistic Prostate Cancer Testing","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2025.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}